Specialty Practice

Sell-side M&A advisory for plastic surgery practice owners

We represent solo and multi-physician plastic surgery practices — including hybrid aesthetic and med-spa operations — in confidential transactions with family offices, PE-backed aesthetic platforms, and strategic acquirers.

Speak with an advisor: (800) 815-0590

Request a Confidential Valuation

Senior advisor will respond within one business day.

100% confidential. No obligation.

Plastic Surgery Track Record

Sell-side experience across solo aesthetic, multi-physician, and hybrid plastic / med-spa practices

Buyer Network

Family offices · PE-backed aesthetic platforms · Med-spa consolidators

How We Help

Three engagement profiles for plastic surgery sellers

Most plastic surgery sell-side engagements fall into one of three patterns. Each requires a materially different process, buyer pool, and deal structure.

Profile 1

Solo cosmetic plastic surgeon sale or recap

For high-revenue solo aesthetic practices — often built around the surgeon's personal brand. We help you structure a sale or recapitalization that monetizes the business while protecting the personal goodwill that drives ongoing revenue.

Discuss your practice →
Profile 2

Multi-physician practice partial sale

For established groups with multiple surgeons, where succession, partnership transition, or strategic capital is the driver. We structure deals that balance the interests of different partners while creating a unified platform attractive to institutional buyers.

Discuss your group →
Profile 3

Hybrid aesthetic platform sale

For practices combining plastic surgery, injectables, and med-spa services into a meaningful platform — the most valuable profile in this segment today. We position you with the aesthetic platforms, med-spa consolidators, and family offices that pay premium multiples for integrated operations.

Discuss your platform →

The Plastic Surgery M&A Market

An emerging market with the widest multiple range in healthcare

Plastic surgery has consolidated more slowly than dental or dermatology, but the market has shifted meaningfully in the last several years. Family offices, PE-backed aesthetic platforms, and med-spa consolidators are now actively acquiring premium practices — particularly those with strong cash-pay aesthetic mixes and integrated ancillary services.

The cash-pay nature of aesthetic plastic surgery creates both opportunity and complexity. Premium practices command some of the highest multiples in middle-market healthcare, but pricing varies more widely than in mature specialties because buyer types — family office, platform, strategic — value the same practice very differently.

Personal goodwill concentration, marketing engine dependence, and surgical-vs-non-surgical revenue split are all closely scrutinized by sophisticated buyers. Direct outreach almost never surfaces the highest-and-best offer in this segment; a properly structured process consistently does.

[ Photo: operating suite, aesthetic consult room, or surgeon portrait ]

Why It Matters

When acquirers come to you directly, you only see one number.

A direct offer from a family office or platform is rarely the best offer — and on your own, you have no way of knowing what it isn't. Our process puts your practice in front of the right competing buyers under NDA, surfacing the highest defensible value and the deal structures (rollover, earn-outs, real estate, med-spa integration) that actually fit your situation. The cost of running a process is a fraction of the value it surfaces.

Our Process

Valuation Drivers

What drives a plastic surgery practice's M&A multiple

The headline multiple is the visible number, but it's the product of a dozen underlying inputs. Knowing how buyers weight each one — and where your practice sits on each — is the difference between accepting an offer and negotiating one.

EBITDA growth trajectory & margin profile
Buyers underwrite the future, not the past. Two practices with identical EBITDA can sell at materially different multiples if one has a clear growth story and the other doesn't. We help you frame and defend the trajectory before going to market.
Cash-pay aesthetic mix (vs reconstructive)
The percentage of revenue from cash-pay aesthetic procedures versus insurance-based reconstructive work is the single largest valuation lever in this specialty. Aesthetic-heavy practices command meaningfully higher multiples.
Surgical vs non-surgical revenue split
Recurring non-surgical injectable revenue (Botox, fillers, laser, body contouring) creates a stickier, more predictable revenue base that buyers reward. Pure surgical practices price differently than integrated aesthetic operations.
Surgical volume & OR utilization
Surgical case volume per surgeon and how efficiently the OR is utilized are key margin drivers and capacity signals. Buyers will model both before and after the deal closes.
Med-spa integration & ancillary revenue
A well-integrated med-spa under the same roof can dramatically expand both revenue and multiple. Buyers price an established aesthetic ecosystem materially higher than a stand-alone surgical practice.
Brand strength & personal goodwill concentration
How much of the practice's value is tied to the founding surgeon's personal brand is the most-modeled risk in plastic surgery diligence. We help you de-risk this for buyers without diminishing the brand itself.
Marketing engine & patient acquisition
The cost, channel mix, and predictability of patient acquisition is closely scrutinized. Practices with a proven, transferable marketing engine command higher multiples than those reliant on referrals alone.
Continuing surgeon commitment
Nearly every plastic surgery transaction includes the seller remaining clinically and visibly for 3–5 years post-close. Your commitment, compensation structure, equity rollover, and brand-licensing terms are among the most negotiable levers in the entire deal.

Recent Closings

Select plastic surgery transactions

View all transactions →

Placeholder data — replace with real closed plastic surgery engagements.

Plastic Surgery
Solo aesthetic practice recapitalized by a family office
Deal TypeRecapitalization
BuyerFamily Office
RegionSoutheast
Year2024
Plastic Surgery
Multi-physician aesthetic group sold to a regional platform
Deal TypeFull Sale
BuyerRegional Platform
RegionWest
Year2023
Plastic Surgery
Plastic surgery and med-spa hybrid sold to an aesthetic consolidator
Deal TypeMajority Sale
BuyerAesthetic Platform
RegionNortheast
Year2023

Know Your Options

Find out what your plastic surgery practice is worth.

Every plastic surgery practice owner — solo, group, or hybrid aesthetic operation — benefits from a confidential conversation about valuation, deal structure, and timing before engaging with buyers directly. Complete the form or call and speak with a senior advisor today.

(800) 815-0590

Request a Confidential Valuation

Senior advisor will respond within one business day.

100% confidential. No obligation.